Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-12-07

Clinical Trial Update: A Futility Trial of Sirolimus in Multiple System Atrophy [Phase 2]

View source ↗

Summary

Phase 2 futility trial of sirolimus in Multiple System Atrophy was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sirolimus (Sirolimus)

Snippet

Sponsor: NYU Langone Health | Conditions: Multiple System Atrophy | Phase 2 | Status: TERMINATED | Results posted: 2021-12-07